NCT07667699

Brief Summary

The goal of this observational study is to learn about the multidimensional determinants of functional health in women aged 45 to 60 years. The study will focus on the role of muscle strength, bone mineral density, body composition, physical activity, sleep quality, depressive symptoms, and menopause-related symptoms in functional health. The main questions it aims to answer are:

  • Undergo handgrip strength measurement
  • Perform a 30-second chair stand test
  • Undergo bone mineral density and body composition assessment
  • Complete questionnaires about physical activity, sleep quality, depressive symptoms, menopausal symptoms, and quality of life
  • Provide demographic and clinical information

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
5mo left

Started Jun 2026

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress24%
Jun 2026Dec 2026

First Submitted

Initial submission to the registry

June 8, 2026

Completed
7 days until next milestone

Study Start

First participant enrolled

June 15, 2026

Completed
10 days until next milestone

First Posted

Study publicly available on registry

June 25, 2026

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

June 25, 2026

Status Verified

June 1, 2026

Enrollment Period

7 months

First QC Date

June 8, 2026

Last Update Submit

June 19, 2026

Conditions

Keywords

MenopausePerimenopauseBone mineral densitySarcopeniaSleep QualityQuality of life

Outcome Measures

Primary Outcomes (1)

  • Physical Functional Performance Score assessed by 30-Second Chair Stand Test and Hand-Grip Dynamometry (composite z-score)

    Functional performance will be operationalised as a composite of two validated measures: (1) number of repetitions completed in the 30-second chair stand test as a measure of lower extremity strength, and (2) dominant hand grip strength (kg) will be measured by calibrated hydraulic hand dynamometer following EWGSOP2 protocol. A standardised composite functional performance z-score will be derived by summing the z-scores of both measures. The primary analysis will examine the independent contributions of bone mineral density and skeletal muscle mass to this composite score using multivariable linear regression and structural equation modelling (SEM).

    Baseline

Secondary Outcomes (14)

  • Bone Mineral Density measured by DXA (g/cm²)

    Baseline

  • Hand-Grip Strength measured by hydraulic hand dynamometer (kg)

    Baseline

  • Lower Extremity Functional Strength assessed by 30-Second Chair Stand Test (number of repetitions)

    Baseline

  • Total Body Fat Mass measured by BIA (kg)

    Baseline

  • Total Body Fat Percentage measured by BIA (%)

    Baseline

  • +9 more secondary outcomes

Other Outcomes (15)

  • Serum 25-Hydroxyvitamin D concentration (nmol/L)

    Baseline

  • Serum Calcium concentration (mmol/L)

    Baseline

  • Serum Phosphorus concentration (mmol/L)

    Baseline

  • +12 more other outcomes

Eligibility Criteria

Age45 Years - 60 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

The study population will be drawn from women attending the Obstetrics and Gynecology outpatient clinic of Kartal Dr. Lütfi Kırdar City Hospital, Istanbul, Turkey. Participants will be identified among patients presenting for routine outpatient gynecologic care and will undergo study-specific assessments during a single outpatient visit.

You may qualify if:

  • Women aged 45 to 60 years
  • Ability to read and complete study questionnaires
  • Provision of written informed consent
  • Ability to complete physical performance assessments

You may not qualify if:

  • Acute systemic illness
  • Active malignancy
  • Severe neurological or orthopedic impairment limiting physical performance assessment
  • Cognitive impairment precluding informed consent or questionnaire completion

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (4)

  • Lorentzon M, Johansson H, Harvey NC, Liu E, Vandenput L, McCloskey EV, Kanis JA. Osteoporosis and fractures in women: the burden of disease. Climacteric. 2022 Feb;25(1):4-10. doi: 10.1080/13697137.2021.1951206. Epub 2021 Jul 28.

    PMID: 34319208BACKGROUND
  • Leong DP, Teo KK, Rangarajan S, Lopez-Jaramillo P, Avezum A Jr, Orlandini A, Seron P, Ahmed SH, Rosengren A, Kelishadi R, Rahman O, Swaminathan S, Iqbal R, Gupta R, Lear SA, Oguz A, Yusoff K, Zatonska K, Chifamba J, Igumbor E, Mohan V, Anjana RM, Gu H, Li W, Yusuf S; Prospective Urban Rural Epidemiology (PURE) Study investigators. Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study. Lancet. 2015 Jul 18;386(9990):266-73. doi: 10.1016/S0140-6736(14)62000-6. Epub 2015 May 13.

    PMID: 25982160BACKGROUND
  • Jones CJ, Rikli RE, Beam WC. A 30-s chair-stand test as a measure of lower body strength in community-residing older adults. Res Q Exerc Sport. 1999 Jun;70(2):113-9. doi: 10.1080/02701367.1999.10608028.

    PMID: 10380242BACKGROUND
  • Geraldi MV, Brattemark E, Lorentzon M. Longitudinal associations of dietary intake, physical activity, and short-chain fatty acids with bone development in early postmenopausal women. Osteoporos Int. 2026 Apr;37(4):879-892. doi: 10.1007/s00198-026-07861-6. Epub 2026 Feb 2.

    PMID: 41622331BACKGROUND

MeSH Terms

Conditions

SarcopeniaSleep Initiation and Maintenance Disorders

Condition Hierarchy (Ancestors)

Muscular AtrophyNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsSigns and SymptomsSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersMental Disorders

Study Officials

  • Elif Unlugedik Sayın, MD, PhD

    University of Health Sciences, Kartal Dr Lütfi Kırdar City Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

ELIF UNLUGEDIK SAYIN, MD, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD

Study Record Dates

First Submitted

June 8, 2026

First Posted

June 25, 2026

Study Start

June 15, 2026

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

June 25, 2026

Record last verified: 2026-06